Oral Symptom Experience and Health-Related Quality of Life of Adult Survivors of Hematopoietic Stem Cell Transplantation (HSCT) with Chronic Graft-Versus-Host-Disease (cGVHD)

2.50
Hdl Handle:
http://hdl.handle.net/10755/147168
Type:
Presentation
Title:
Oral Symptom Experience and Health-Related Quality of Life of Adult Survivors of Hematopoietic Stem Cell Transplantation (HSCT) with Chronic Graft-Versus-Host-Disease (cGVHD)
Abstract:
Oral Symptom Experience and Health-Related Quality of Life of Adult Survivors of Hematopoietic Stem Cell Transplantation (HSCT) with Chronic Graft-Versus-Host-Disease (cGVHD)
Conference Sponsor:Sigma Theta Tau International
Conference Year:2007
Author:Fall-Dickson, Jane, RN, PhD
P.I. Institution Name:National Institute of Nursing Research
Title:Investigator
Co-Authors:Sandra Mitchell, MScN; Susan Marden, RN, PhD; Edward Ramsay, BS; Matin Imanguli, DDS; Jean-Pierre Guadagnini, DDS; Jeanne Odom, BSN; Niveen Atlam, BS; Steven Pavletic, MD
[Scientific session research presentation] Background: Oral cGVHD is a serious sequela of HSCT with optimal treatment unknown. This descriptive study assessed stomatitis, oral dryness and pain, HRQL and proinflammatory cytokines in patients with cGVHD enrolled in a NCI natural history protocol. Methods:.Oral Mucositis Rating Scale (OMRS; 0-273) measured stomatitis. VAS (0-10) measured oral dryness and pain severity. Functional Assessment of Cancer Therapy-General (FACT-G) total and subscales (physical [PWB], emotional [EWB] social/family [SWB], and functional [FWB] well-being) assessed HRQL. TNFalpha, IL1alpha, and IL6 concentrations in stimulated submandibular saliva samples were measured by enzyme-linked immunosorbent assay (ELISA) (R & D Systems, Minneapolis, MN). Saliva samples were collected on ice, stored at -80 degrees C, centrifuged at 4000 xg 10 minutes at 4 degrees C and supernatant retained. Analyses included descriptive statistics (mean +/- SD) and Pearson correlation coefficients. Results: Adult participants (N = 32) all had mild stomatitis (OMRS 17.8 +/- 13.4), erythema (91%), lichenoid (72%), ulceration (56%), mild oral dryness (2.2 +/- 3.1; 40%) and mild pain (0.1+/- 0.41; 7%). HRQL was impaired (below General US population norms) except SWB: Total (75.1 +/- 21.2, norm=80); PWB (18.3+/- 6.8, norm=22); EWB (18.0 +/- 4.9, norm=20); FWB (17.5+/- 6.9,  norm=18.5); and SWB (21.2 +/- 6.5, norm=19). TNFalpha 0.30pg/mL +/- 0.6; IL1alpha 84.6pg/mL +/- 67.51; and IL6 2.4pg/mL +/- 2.95. Moderate correlations (p<0.05) seen between TNFalpha and erythema (r=.36), IL1alpha and oral dryness (r=.41), and IL6 and OMRS (r=.49), erythema (r=.63), and ulceration (r=.38). Oral dryness correlated (p<0.05) with PWB (r=-.42), SWB (r=-.40), and total FACT-G (r=-.41). OMRS correlated (p<0.05) with SWB (r=-.49). HRQL and cytokines showed no significant correlations. Conclusions: Oral dryness was more prevalent than oral pain and significantly associated with salivary IL1alpha and poorer physical and social well-being. Moderate to strong associations between salivary TNFalpha and IL6 and oral cGVHD severity, and IL1alpha and oral dryness suggest utility as correlates of disease severity. Oral dryness deserves assessment in this population because it may adversely affect HRQL.
Repository Posting Date:
26-Oct-2011
Date of Publication:
17-Oct-2011
Sponsors:
Sigma Theta Tau International

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleOral Symptom Experience and Health-Related Quality of Life of Adult Survivors of Hematopoietic Stem Cell Transplantation (HSCT) with Chronic Graft-Versus-Host-Disease (cGVHD)en_GB
dc.identifier.urihttp://hdl.handle.net/10755/147168-
dc.description.abstract<table><tr><td colspan="2" class="item-title">Oral Symptom Experience and Health-Related Quality of Life of Adult Survivors of Hematopoietic Stem Cell Transplantation (HSCT) with Chronic Graft-Versus-Host-Disease (cGVHD)</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Sigma Theta Tau International</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2007</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Fall-Dickson, Jane, RN, PhD</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">National Institute of Nursing Research</td></tr><tr class="item-author-title"><td class="label">Title:</td><td class="value">Investigator</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">dicksonj@mail.nih.gov</td></tr><tr class="item-co-authors"><td class="label">Co-Authors:</td><td class="value">Sandra Mitchell, MScN; Susan Marden, RN, PhD; Edward Ramsay, BS; Matin Imanguli, DDS; Jean-Pierre Guadagnini, DDS; Jeanne Odom, BSN; Niveen Atlam, BS; Steven Pavletic, MD</td></tr><tr><td colspan="2" class="item-abstract">[Scientific session research presentation] Background: Oral cGVHD is a serious sequela of HSCT with optimal treatment unknown. This descriptive study assessed stomatitis, oral dryness and pain, HRQL and proinflammatory cytokines in patients with cGVHD enrolled in a NCI natural history protocol. Methods:.Oral Mucositis Rating Scale (OMRS; 0-273) measured stomatitis. VAS (0-10) measured oral dryness and pain severity. Functional Assessment of Cancer Therapy-General (FACT-G) total and subscales (physical [PWB], emotional [EWB] social/family [SWB], and functional [FWB] well-being) assessed HRQL. TNFalpha, IL1alpha, and IL6 concentrations in stimulated submandibular saliva samples were measured by enzyme-linked immunosorbent assay (ELISA) (R &amp; D Systems, Minneapolis, MN). Saliva samples were collected on ice, stored at -80 degrees C, centrifuged at 4000 xg 10 minutes at 4 degrees C and supernatant retained. Analyses included descriptive statistics (mean +/- SD) and Pearson correlation coefficients. Results: Adult participants (N = 32) all had mild stomatitis (OMRS 17.8 +/- 13.4), erythema (91%), lichenoid (72%), ulceration (56%), mild oral dryness (2.2 +/- 3.1; 40%) and mild pain (0.1+/- 0.41; 7%). HRQL was impaired (below General US population norms) except SWB: Total (75.1 +/- 21.2, norm=80); PWB (18.3+/- 6.8, norm=22); EWB (18.0 +/- 4.9, norm=20); FWB (17.5+/- 6.9, &nbsp;norm=18.5); and SWB (21.2 +/- 6.5, norm=19). TNFalpha 0.30pg/mL +/- 0.6; IL1alpha 84.6pg/mL +/- 67.51; and IL6 2.4pg/mL +/- 2.95. Moderate correlations (p&lt;0.05) seen between TNFalpha and erythema (r=.36), IL1alpha and oral dryness (r=.41), and IL6 and OMRS (r=.49), erythema (r=.63), and ulceration (r=.38). Oral dryness correlated (p&lt;0.05) with PWB (r=-.42), SWB (r=-.40), and total FACT-G (r=-.41). OMRS correlated (p&lt;0.05) with SWB (r=-.49). HRQL and cytokines showed no significant correlations. Conclusions: Oral dryness was more prevalent than oral pain and significantly associated with salivary IL1alpha and poorer physical and social well-being. Moderate to strong associations between salivary TNFalpha and IL6 and oral cGVHD severity, and IL1alpha and oral dryness suggest utility as correlates of disease severity. Oral dryness deserves assessment in this population because it may adversely affect HRQL.</td></tr></table>en_GB
dc.date.available2011-10-26T09:29:50Z-
dc.date.issued2011-10-17en_GB
dc.date.accessioned2011-10-26T09:29:50Z-
dc.description.sponsorshipSigma Theta Tau Internationalen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.